Growth hormone deficiency in patients in long-term remission of adrenal Cushing's syndrome

Growth hormone deficiency in patients in long-term remission of adrenal Cushing's syndrome - GH deficiency after adrenal Cushing*s syndrome

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36195

Enrollment

Registered

2011-02-22

Start date

2011-03-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

groeihormoondeficiëntie

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Remission of Cushing*s syndrome due to adrenal adenoma for at least four years. - Proven remission by a 1 mg dexamethasone suppression test within the last year.

Exclusion criteria

Exclusion criteria: - Patients cured of an adrenal carcinoma. - BMI >30 kg/m2.

Design outcomes

Primary

Measure	Time frame
GH secretory response to an ITT or an Arginine/GHRH test. The endpoint is GH deficiency as defined in the consensus of the endocrine society in 2006.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results